Table 1.
Pre-intervention | Post-intervention | |
N | 509 | 492 |
No of men | 292 | 300 |
Age (years) | 77.9±11.2 | 78.6±12.4 |
Weight (kg) | 73.9±17.8 | 72.7±19.9 |
Length of stay (median, range) | 7 (1–154) | 7 (1–84) |
Co-morbidities (median, range) | 3 (0–12) | 3 (0–9) |
Renal function at admission* (ml/min) | 47.4+24.1 | 43.3+22.7 |
ARF (n) | 24 | 16 |
ACEI (n) | 258 | 252 |
Allopurinol (n) | 50 | 54 |
Digoxin (n) | 98 | 80 |
Enoxaparin (n) | 44 | 58 |
Furosemide (n)* | 204 | 233 |
Gentamicin (n)* | 77 | 38 |
Lithium (n) | 1 | 1 |
Metformin (n) | 64 | 60 |
Vancomycin (n)* | 37 | 17 |
Mean (±1 SD) unless otherwise stated.
p<0.05 for difference between pre and post-intervention period.
ACEI, angiotensin-converting enzyme inhibitor; ARF, acute renal failure.